Influence of ORM1, PXR, CAR, CYP3A4 and CYP3A5 gene polymorphisms in mediating susceptibility risk to chronic myeloid leukaemia and response to imatinib mesylate therapy

Genetic polymorphisms are well recognized sources of individual differences in disease risk and treatment response. Associations between human genetic variants and predisposition to diseases and adverse events for different kinds of drug interactions with hundreds of protein like receptors, trans...

وصف كامل

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Maddin, Najlaa
التنسيق:	أطروحة
اللغة:	الإنجليزية
منشور في:	2017
الموضوعات:	R Medicine (General)
الوصول للمادة أونلاين:	http://eprints.usm.my/43138/
Abstract	Abstract here

مواد مشابهة

Genetic determinants excluding GBCR::ABL mutations of imatinib mesylate therapy response among chronic myeloid leukaemia patients in Malaysia
حسب: Ismail, Siti Mariam
منشور في: (2023)

Influence of tert gene expression, telomerase activity and telomere length in relation to imatinib mesylate resistance in Malaysian chronic myeloid leukaemia patients
حسب: Shamshudin, Wati @ Hayati Mohd
منشور في: (2020)

Determination of gene copy number status in tert and terc among chronic myeloid leukaemia patients resist ant and responsive to imatinib mesylate treatment
حسب: Asrari, Zaidatul Shakila Mohamad
منشور في: (2014)

Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8
حسب: Abu Bakar, Ruzilawati
منشور في: (2008)

The impact of CYP3A4 and CYP3A5 polymorphisms on anastrozole's pharmacokinetics and pharmacodynamics in post-menopausal breast cancer patients
حسب: Abubakar, Murtala Bello
منشور في: (2017)

Detection of PDGFRA mutations at exons 12 and 18 among chronic myeloid leukemia patients treated with imatinib mesylate
حسب: Razali, Ruzi Hamimi
منشور في: (2015)

Molecular genetic and epigenetic mechanisms of primary and secondary resistance to imatinib mesylate treatment in ph chromosome positive chronic myeloid leukemia patients
حسب: Elias, Marjanu Hikmah
منشور في: (2015)

The influence of genetic polymorphisms of CYP3A on the pharmacokinetic variation and clinical outcomes of tacrolimus in a cohort of patients / Mohd Rahimi Muda
حسب: Muda, Mohd Rahimi
منشور في: (2014)

Interaction of bile pigments and 4 (methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) with CYP2A6 and CYP2A13 / Nurnadia Majid
حسب: Majid, Nurnadia
منشور في: (2023)

FLT3, NPM1, DNMT3a and NRAS genes mutation in acute myeloid leukaemia in HUSM
حسب: Mat Yunus, Noraini
منشور في: (2015)

Influence Of Cyp2d6 And Drd2 Polymorphisms On Clinical Outcomes Of Patients With Schizophrenia
حسب: Zahari, Zalina
منشور في: (2009)

Genetic Polymorphisms In The CYP2A6: Implications For Inter-Individual Differences In Nicotine Metabolism
حسب: Musa, Nurfadhlina
منشور في: (2006)

Investigation of genetic polymorphism of CYP2C9 in patient on warfarin therapy and the clinical relevance
حسب: Harris Ngow Abdullah
منشور في: (2024)

WRL68-CYP3A4 and WRL68-CYP2C9 mutagenesis in vitro drug metabolism models for the assessment drug-herb interactions / Nurliana Abd Mutalib
حسب: Abd Mutalib, Nurliana
منشور في: (2022)

Anti-hepatitis a virus seroprev alence among chronic viral hepatitis band c liver disease in husm and its association with cyp3a4*18 polymorphism
حسب: Fazlina, Ahmad
منشور في: (2010)

The Clinical Significance Of Npm1, Flt3 And Cebpa Gene Mutations In Adult Patients With Acute Myeloid Leukaemia
حسب: Ul Haq, Izaz
منشور في: (2020)

Cloning and expression of CYP2D6*1 and CYP2D6*10 and its application in vitro drug-herbs interaction studies
حسب: Lee, Wee Leng
منشور في: (2013)

Molecular Mechanism Of Synthetic Microrna Underlying Chronic Myeloid Leukaemia Cells Proliferation By Targeting The 3’UTR Of ABL1 Component Of The BCR-ABL1 Fusion Gene
حسب: Syarifah Faezah Syed Mohamad
منشور في: (2025)

Establishment Of in vitro Plantlets Of Artemisia annua L. For The Analysis Of Artemisinin Biosynthetic Gene (CYP71AV1) And Trichome Initiation Gene (GL3)
حسب: Suganthi , Appalasamy
منشور في: (2014)

Gene Expression Profile And Modulation Of Genetic Pathways In Acute Myeloid Leukaemia T(8;21)
حسب: Bashanfer, Salem Ali Alsalem
منشور في: (2013)

Utilization of chemotherapy regimen for acute myeloid leukaemia patients in Ampang Hospital / Jamaliah Jamari
حسب: Jamari, Jamaliah
منشور في: (2015)

Utilization of Chemotherapy Regimen for acute Myeloid Leukaemia Patients in Ampang Hospital / Jamaliah Jamari
حسب: Jamari, Jamaliah
منشور في: (2015)

Application of high resolution melting (HRM) analysis in detection of PDGFRA gene mutations among chronic myeloid leukemia patients treated with imanitib mesylate
حسب: Rashid, Nur Sabrina Abd
منشور في: (2020)

The implication of the polymorphism of COX-1, UGT1A6, and CYP2C9 among cardiovascular disease (CVD) patients treated with aspirin / Nur Jalinna Abdul Jalil
حسب: Abdul Jalil, Nur Jalinna
منشور في: (2014)

Development of thermostabilized pcr method for the simultaneous detection of SNPS of CYP2B6 and OPRM1 genes.
حسب: KC, Sanjaya
منشور في: (2011)

Ultra-high performance liquid chromatography (uhplc) method development and validation for the determination of serum imatinib and its active metabolite concentration among chronic myeloid leukemia patients
حسب: Liong, Tan Ka
منشور في: (2013)

Survival rate and prognostic factors of survival among chronic myeloid leukaemia adults after initiation of tyrosine kinase inhibitor therapy in Hospital Ampang, Selangor
حسب: Ali, Zakiah Bakar
منشور في: (2024)

The generation of CYP2C9 knocked-down human hepatocyte library: a utilization of crispr/cas9 system / Ruhil Nadirah Che Omar
حسب: Che Omar, Ruhil Nadirah
منشور في: (2024)

Development of a heterologous human CYP2C9-NADPH P450 reductase system: An in vitro enzyme system for drug metabolism study / Riza Afzan Asri
حسب: Asri, Riza Afzan
منشور في: (2010)

A Study On Cyp2c19 Genetic Variations Of Clopidogrel And Ticagrelor Treatment Among Coronary Artery Disease (CAD) Patients Undergoing Percutaneous Coronary Intervention (PCI)
حسب: Ak-Kaif, Mohammed Ahmed Imran
منشور في: (2023)

Effects Of Chrysin On The mRNA Expression Of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) And Cyp Genes, Cell Cycle And Cell Migration In Colorectal Cancer Hct-116 Cells
حسب: Khor, Chin Yin
منشور في: (2020)

A pharmacogenetic study of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase complex 1 (VKORCl) / Immaculate Mbongo Langmia
حسب: Mbongo Langmia, Immaculate
منشور في: (2011)

Cytogenomic profiling of chronic lymphocytic leukaemia patients using dna microarray
حسب: Zamri, Wan Norizzati Wan Mohamad
منشور في: (2021)

Detection of fms-like tyrosine kinase 3 (FLT3) and nucleophosmin 1 (NPM1) mutations from formalin fixed paraffin embedded marrow tissues in patients with myeloid neoplasms
حسب: Mansoor, Mohammad Naeem
منشور في: (2024)

Detection of leukaemia-associated aberrant immunophenotype (LAIPs) in acute leukaemia and its association with haematological parameters and treatment outcome
حسب: Rahman, Noor Shaidatul Akmal Ab
منشور في: (2017)

Genetic Polymorphisms In The Phase I And Phase II Xenobiotic Metabolizing Enzymes In Malaysian Population And Their Influence On Colorectal Cancer Susceptibility
حسب: Shahpudin, Siti Nurfatimah Mohd
منشور في: (2012)

Nuclear factor kappa b genetic polymorphisms and association with colorectal cancer susceptibility risk in malaysian population - A molecular epidemiology study
حسب: Shafi’i, Mohd Suza1ri Mohd
منشور في: (2013)

Treatment outcome of children with acute lymphoblastic leukaemia in HUSM
حسب: Nik Nasiruddin, Nik Leh
منشور في: (2007)

Genotyping of single nucleotide polymorphisms (SNPs) of CTLA-4 and FOXP3 genes in lymphatic filariasis and schistosomiasis.
حسب: Idris, Zulkarnain Md
منشور في: (2011)

Study on the serum and gene expression profile of cytokines and the role of cytokine gene polymorphism on susceptibility to hepatitis c infection in Malay male drug abusers
حسب: Noh, Che Ismail Che
منشور في: (2023)